May
24
2022
On demand

Streamlined workflow solutions for cell and gene therapy analytics

Sponsor
Streamlined workflow solutions for cell and gene therapy analytics

Throughout preclinical development and cell and gene therapy commercialization, analytical assays are essential to produce safe and potent drug products. Despite their importance, conventional analytical assays often consist of complex manual handling steps. Therefore, it can be unclear whether variations measured come from the drug product or if they have been unwittingly introduced by the operator or technology used. 

Miltenyi Biotec has compiled a complete workflow solution for precise, easy-to-handle and fast cell and gene therapy analytical assays to overcome these challenges in early discovery, cell therapy quality control during manufacturing, and patient monitoring research. Join this webinar to discover how standardization and automation enable a smooth transition from early discovery to clinical readiness!

  • Facilitate target discovery through imaging platform selection 
  • Minimize non-specific background signal from antibodies and CAR detection reagents
  • Accelerate your workflow and increase reproducibility using dry antibody cocktails
  • Analyze multiple cytokines in parallel using multiplex cytokine assays

  • Enable fully automated data acquisition and analysis on MACSQuant flow cytometers

Annika Graband

Product Manager, Cell Analysis Reagents, Miltenyi Biotec

Annika is Miltenyi Biotec’s Product Manager responsible for the cell and gene therapy reagents portfolio, including CAR detection reagents and StainExpress™ dry antibody cocktails. During the past year, she has been working together with R&D to advance the development of tools that enable highly reliable and standardized cell and gene therapy analytics

SPEAKERS

Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec

You might also like